Kern Singh
Concepts (399)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Fusion | 147 | 2022 | 464 | 51.600 |
Why?
| Lumbar Vertebrae | 99 | 2022 | 469 | 33.710 |
Why?
| Minimally Invasive Surgical Procedures | 58 | 2022 | 300 | 21.790 |
Why?
| Diskectomy | 57 | 2022 | 181 | 19.910 |
Why?
| Cervical Vertebrae | 63 | 2022 | 343 | 18.980 |
Why?
| Postoperative Complications | 57 | 2022 | 1083 | 11.340 |
Why?
| Spinal Diseases | 26 | 2021 | 153 | 10.210 |
Why?
| Retrospective Studies | 117 | 2022 | 3591 | 9.230 |
Why?
| Length of Stay | 42 | 2020 | 377 | 8.790 |
Why?
| Lumbosacral Region | 22 | 2022 | 71 | 8.350 |
Why?
| Spondylolisthesis | 14 | 2022 | 46 | 7.840 |
Why?
| Hospital Costs | 26 | 2020 | 73 | 7.680 |
Why?
| Treatment Outcome | 88 | 2022 | 3910 | 7.250 |
Why?
| Middle Aged | 138 | 2022 | 11209 | 6.950 |
Why?
| Decompression, Surgical | 20 | 2021 | 146 | 6.860 |
Why?
| Pain, Postoperative | 21 | 2022 | 306 | 6.750 |
Why?
| Humans | 217 | 2022 | 31481 | 6.640 |
Why?
| Intervertebral Disc Degeneration | 12 | 2021 | 117 | 6.000 |
Why?
| Male | 143 | 2022 | 17583 | 5.770 |
Why?
| Narcotics | 10 | 2020 | 33 | 5.560 |
Why?
| Female | 138 | 2022 | 18253 | 5.480 |
Why?
| Adult | 104 | 2022 | 9779 | 5.350 |
Why?
| Orthopedic Procedures | 20 | 2020 | 322 | 5.020 |
Why?
| Spine | 13 | 2021 | 125 | 4.510 |
Why?
| Mental Health | 7 | 2022 | 119 | 4.300 |
Why?
| Aged | 83 | 2021 | 10295 | 3.910 |
Why?
| Intervertebral Disc | 14 | 2020 | 243 | 3.770 |
Why?
| Prospective Studies | 36 | 2022 | 1934 | 3.620 |
Why?
| Bone Morphogenetic Proteins | 12 | 2017 | 100 | 3.560 |
Why?
| Surgeons | 7 | 2022 | 84 | 3.290 |
Why?
| Pain Measurement | 16 | 2022 | 476 | 3.180 |
Why?
| Reoperation | 12 | 2019 | 938 | 3.000 |
Why?
| Incidence | 30 | 2018 | 829 | 2.920 |
Why?
| Risk Factors | 38 | 2021 | 2664 | 2.890 |
Why?
| Databases, Factual | 23 | 2022 | 391 | 2.860 |
Why?
| Postoperative Care | 10 | 2021 | 141 | 2.830 |
Why?
| Laminectomy | 7 | 2019 | 66 | 2.810 |
Why?
| Bone Transplantation | 9 | 2019 | 231 | 2.770 |
Why?
| Body Mass Index | 6 | 2019 | 458 | 2.720 |
Why?
| Ilium | 5 | 2019 | 29 | 2.680 |
Why?
| Inpatients | 16 | 2019 | 154 | 2.640 |
Why?
| Disability Evaluation | 12 | 2022 | 332 | 2.540 |
Why?
| Workers' Compensation | 6 | 2022 | 50 | 2.530 |
Why?
| Young Adult | 34 | 2020 | 2277 | 2.510 |
Why?
| Neck Pain | 7 | 2022 | 27 | 2.460 |
Why?
| Spinal Cord Diseases | 6 | 2022 | 51 | 2.450 |
Why?
| Back Pain | 8 | 2022 | 49 | 2.440 |
Why?
| Patient Satisfaction | 6 | 2022 | 315 | 2.440 |
Why?
| Social Media | 3 | 2022 | 35 | 2.410 |
Why?
| Bibliometrics | 3 | 2022 | 22 | 2.410 |
Why?
| Thoracic Vertebrae | 11 | 2017 | 117 | 2.380 |
Why?
| Information Systems | 3 | 2021 | 18 | 2.330 |
Why?
| Analgesics, Opioid | 8 | 2022 | 211 | 2.310 |
Why?
| Bone Morphogenetic Protein 2 | 8 | 2016 | 45 | 2.220 |
Why?
| Transforming Growth Factor beta | 9 | 2016 | 126 | 2.200 |
Why?
| Adolescent | 33 | 2021 | 2667 | 2.200 |
Why?
| Recovery of Function | 9 | 2021 | 309 | 2.150 |
Why?
| Preoperative Care | 3 | 2020 | 146 | 2.130 |
Why?
| Deglutition Disorders | 8 | 2022 | 47 | 2.050 |
Why?
| Postoperative Period | 15 | 2021 | 295 | 2.030 |
Why?
| Analgesia, Patient-Controlled | 3 | 2020 | 28 | 2.020 |
Why?
| Periodicals as Topic | 3 | 2020 | 46 | 1.990 |
Why?
| Health Care Costs | 6 | 2017 | 81 | 1.960 |
Why?
| Decompression | 6 | 2022 | 8 | 1.920 |
Why?
| Intervertebral Disc Displacement | 6 | 2019 | 121 | 1.850 |
Why?
| Pain Management | 3 | 2021 | 139 | 1.830 |
Why?
| Cohort Studies | 19 | 2021 | 2014 | 1.830 |
Why?
| Ambulatory Surgical Procedures | 3 | 2020 | 81 | 1.800 |
Why?
| United States | 25 | 2020 | 2539 | 1.730 |
Why?
| Operative Time | 15 | 2019 | 97 | 1.710 |
Why?
| Total Disc Replacement | 4 | 2021 | 15 | 1.650 |
Why?
| Patient Participation | 2 | 2020 | 52 | 1.490 |
Why?
| Spinal Stenosis | 6 | 2013 | 53 | 1.460 |
Why?
| Quality Improvement | 6 | 2019 | 173 | 1.450 |
Why?
| Patient Acceptance of Health Care | 2 | 2020 | 85 | 1.440 |
Why?
| Comorbidity | 12 | 2021 | 562 | 1.390 |
Why?
| Registries | 9 | 2020 | 214 | 1.350 |
Why?
| Sex Characteristics | 2 | 2019 | 128 | 1.350 |
Why?
| Conflict of Interest | 2 | 2019 | 19 | 1.350 |
Why?
| Hospitals | 5 | 2019 | 142 | 1.340 |
Why?
| Multivariate Analysis | 10 | 2020 | 390 | 1.320 |
Why?
| Heart Diseases | 3 | 2014 | 102 | 1.320 |
Why?
| Patient Preference | 3 | 2018 | 36 | 1.280 |
Why?
| Arthrodesis | 4 | 2017 | 36 | 1.280 |
Why?
| Arthroplasty | 2 | 2019 | 125 | 1.250 |
Why?
| Aged, 80 and over | 24 | 2020 | 5234 | 1.230 |
Why?
| Neurosurgical Procedures | 4 | 2022 | 169 | 1.230 |
Why?
| Societies, Medical | 2 | 2020 | 209 | 1.230 |
Why?
| Arm | 3 | 2022 | 78 | 1.220 |
Why?
| Learning Curve | 3 | 2016 | 19 | 1.210 |
Why?
| Costs and Cost Analysis | 6 | 2017 | 39 | 1.190 |
Why?
| Depression | 2 | 2021 | 516 | 1.190 |
Why?
| Radiography | 12 | 2022 | 717 | 1.180 |
Why?
| Bone Development | 2 | 2017 | 34 | 1.180 |
Why?
| Reproducibility of Results | 9 | 2021 | 886 | 1.160 |
Why?
| Hospitals, Teaching | 3 | 2014 | 37 | 1.110 |
Why?
| Scoliosis | 2 | 2022 | 35 | 1.110 |
Why?
| Radiculopathy | 5 | 2021 | 59 | 1.110 |
Why?
| Pneumonia | 2 | 2016 | 74 | 1.100 |
Why?
| Lordosis | 2 | 2020 | 32 | 1.080 |
Why?
| Orthopedics | 4 | 2020 | 133 | 1.050 |
Why?
| Motivation | 2 | 2022 | 102 | 1.030 |
Why?
| Tomography, X-Ray Computed | 8 | 2020 | 891 | 1.030 |
Why?
| Journal Impact Factor | 2 | 2022 | 15 | 1.010 |
Why?
| Low Back Pain | 3 | 2021 | 133 | 1.010 |
Why?
| Health Surveys | 2 | 2021 | 102 | 1.010 |
Why?
| Obesity | 5 | 2022 | 338 | 1.000 |
Why?
| Follow-Up Studies | 11 | 2022 | 2028 | 0.960 |
Why?
| Patient Positioning | 2 | 2021 | 35 | 0.950 |
Why?
| Disclosure | 2 | 2020 | 19 | 0.950 |
Why?
| Time Factors | 12 | 2020 | 1902 | 0.920 |
Why?
| Surgical Wound Infection | 3 | 2016 | 106 | 0.920 |
Why?
| Intraoperative Complications | 4 | 2020 | 76 | 0.910 |
Why?
| Bone Plates | 4 | 2022 | 57 | 0.900 |
Why?
| Visual Analog Scale | 5 | 2021 | 49 | 0.890 |
Why?
| Insurance | 1 | 2022 | 2 | 0.880 |
Why?
| Physical Examination | 2 | 2021 | 116 | 0.870 |
Why?
| Robotic Surgical Procedures | 1 | 2022 | 22 | 0.850 |
Why?
| Sacrum | 1 | 2021 | 30 | 0.840 |
Why?
| Age Factors | 9 | 2016 | 943 | 0.840 |
Why?
| Perioperative Care | 5 | 2019 | 75 | 0.830 |
Why?
| Internal Fixators | 2 | 2020 | 53 | 0.830 |
Why?
| Quality of Life | 5 | 2022 | 663 | 0.820 |
Why?
| Diabetes Complications | 1 | 2021 | 74 | 0.810 |
Why?
| Physicians | 2 | 2020 | 120 | 0.800 |
Why?
| Ownership | 1 | 2020 | 5 | 0.800 |
Why?
| Opioid-Related Disorders | 1 | 2021 | 55 | 0.800 |
Why?
| Urinary Retention | 2 | 2020 | 12 | 0.790 |
Why?
| Blood Loss, Surgical | 6 | 2019 | 71 | 0.790 |
Why?
| Analgesics | 1 | 2021 | 103 | 0.780 |
Why?
| Industry | 1 | 2020 | 11 | 0.780 |
Why?
| Interinstitutional Relations | 1 | 2020 | 11 | 0.780 |
Why?
| Outpatients | 2 | 2020 | 56 | 0.770 |
Why?
| Health Resources | 2 | 2017 | 28 | 0.760 |
Why?
| Psoas Muscles | 2 | 2017 | 6 | 0.760 |
Why?
| Pinch Strength | 1 | 2019 | 1 | 0.760 |
Why?
| Tobacco Use | 1 | 2019 | 7 | 0.760 |
Why?
| Spinal Cord Injuries | 2 | 2017 | 43 | 0.750 |
Why?
| Hand Strength | 1 | 2019 | 61 | 0.730 |
Why?
| Logistic Models | 8 | 2017 | 479 | 0.730 |
Why?
| Patient Education as Topic | 2 | 2018 | 192 | 0.720 |
Why?
| Bone Anteversion | 1 | 2019 | 1 | 0.720 |
Why?
| Health Information Systems | 1 | 2019 | 2 | 0.720 |
Why?
| Patients | 2 | 2016 | 26 | 0.720 |
Why?
| Zygapophyseal Joint | 2 | 2012 | 47 | 0.710 |
Why?
| Authorship | 1 | 2018 | 16 | 0.690 |
Why?
| Venous Thrombosis | 3 | 2014 | 51 | 0.690 |
Why?
| Hospitalization | 4 | 2014 | 359 | 0.690 |
Why?
| Reconstructive Surgical Procedures | 3 | 2012 | 226 | 0.690 |
Why?
| Preoperative Period | 2 | 2019 | 73 | 0.680 |
Why?
| Steroids | 1 | 2018 | 30 | 0.670 |
Why?
| Hip Dislocation | 1 | 2019 | 59 | 0.670 |
Why?
| Lumbosacral Plexus | 1 | 2017 | 6 | 0.660 |
Why?
| Reading | 1 | 2018 | 41 | 0.660 |
Why?
| Congresses as Topic | 1 | 2017 | 36 | 0.650 |
Why?
| Foramen Magnum | 1 | 2017 | 5 | 0.650 |
Why?
| Postural Balance | 1 | 2019 | 127 | 0.640 |
Why?
| Recombinant Proteins | 7 | 2016 | 295 | 0.630 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 224 | 0.630 |
Why?
| Neurosurgery | 1 | 2018 | 49 | 0.630 |
Why?
| Spondylolysis | 1 | 2017 | 3 | 0.630 |
Why?
| Overweight | 2 | 2016 | 67 | 0.630 |
Why?
| Hypoalbuminemia | 1 | 2016 | 3 | 0.620 |
Why?
| Internet | 1 | 2018 | 103 | 0.610 |
Why?
| Pulmonary Embolism | 3 | 2015 | 57 | 0.610 |
Why?
| Kyphosis | 2 | 2008 | 26 | 0.600 |
Why?
| Anesthetics | 1 | 2016 | 24 | 0.600 |
Why?
| Occupational Injuries | 1 | 2016 | 9 | 0.600 |
Why?
| Malnutrition | 1 | 2016 | 21 | 0.600 |
Why?
| Patient Discharge | 2 | 2022 | 163 | 0.600 |
Why?
| Bupivacaine | 2 | 2007 | 55 | 0.590 |
Why?
| Patient Selection | 1 | 2018 | 264 | 0.580 |
Why?
| Calcium Phosphates | 2 | 2014 | 30 | 0.580 |
Why?
| Anesthetics, Local | 2 | 2007 | 86 | 0.570 |
Why?
| Choice Behavior | 1 | 2016 | 61 | 0.560 |
Why?
| Foraminotomy | 1 | 2015 | 8 | 0.560 |
Why?
| Hospital Mortality | 5 | 2014 | 192 | 0.560 |
Why?
| Attitude to Health | 1 | 2016 | 117 | 0.560 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 230 | 0.560 |
Why?
| Illinois | 3 | 2020 | 266 | 0.550 |
Why?
| Urinary Tract Infections | 1 | 2015 | 34 | 0.550 |
Why?
| Occupational Diseases | 1 | 2015 | 26 | 0.550 |
Why?
| Regression Analysis | 4 | 2020 | 319 | 0.550 |
Why?
| Chi-Square Distribution | 5 | 2016 | 178 | 0.540 |
Why?
| Survival Rate | 5 | 2013 | 465 | 0.540 |
Why?
| Athletic Injuries | 1 | 2017 | 182 | 0.540 |
Why?
| Cardiovascular Diseases | 1 | 2019 | 410 | 0.520 |
Why?
| Silicates | 1 | 2014 | 1 | 0.510 |
Why?
| Calcium Compounds | 1 | 2014 | 2 | 0.510 |
Why?
| Self Report | 1 | 2015 | 225 | 0.510 |
Why?
| Airway Management | 1 | 2014 | 11 | 0.510 |
Why?
| Intubation, Intratracheal | 2 | 2018 | 70 | 0.510 |
Why?
| Ileus | 1 | 2013 | 4 | 0.500 |
Why?
| Bone Screws | 3 | 2012 | 178 | 0.500 |
Why?
| Blindness | 1 | 2013 | 15 | 0.500 |
Why?
| Pneumonia, Aspiration | 1 | 2013 | 9 | 0.490 |
Why?
| Arthroplasty, Replacement | 2 | 2006 | 147 | 0.490 |
Why?
| Patient Readmission | 5 | 2019 | 129 | 0.490 |
Why?
| Venous Thromboembolism | 2 | 2018 | 53 | 0.490 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2013 | 29 | 0.480 |
Why?
| Delirium | 1 | 2013 | 41 | 0.480 |
Why?
| Single-Blind Method | 4 | 2018 | 132 | 0.480 |
Why?
| Dementia | 1 | 2019 | 545 | 0.480 |
Why?
| Surgical Procedures, Operative | 1 | 2013 | 40 | 0.470 |
Why?
| Vertebroplasty | 2 | 2009 | 11 | 0.440 |
Why?
| Fractures, Compression | 2 | 2009 | 7 | 0.440 |
Why?
| Atlanto-Axial Joint | 1 | 2011 | 19 | 0.430 |
Why?
| Polymethyl Methacrylate | 3 | 2007 | 16 | 0.430 |
Why?
| Magnetic Resonance Imaging | 4 | 2017 | 1273 | 0.420 |
Why?
| Clinical Trials as Topic | 2 | 2018 | 378 | 0.420 |
Why?
| Extracellular Matrix | 2 | 2009 | 92 | 0.410 |
Why?
| Joint Instability | 2 | 2012 | 374 | 0.410 |
Why?
| Arthroplasty, Replacement, Hip | 1 | 2019 | 840 | 0.400 |
Why?
| Proteoglycans | 3 | 2009 | 419 | 0.380 |
Why?
| Sex Factors | 3 | 2018 | 542 | 0.380 |
Why?
| Stroke | 1 | 2014 | 367 | 0.380 |
Why?
| Spinal Injuries | 2 | 2015 | 29 | 0.380 |
Why?
| Shoulder Joint | 1 | 2015 | 560 | 0.380 |
Why?
| Data Collection | 3 | 2020 | 120 | 0.370 |
Why?
| Collagen | 2 | 2009 | 111 | 0.360 |
Why?
| Treatment Failure | 2 | 2021 | 187 | 0.360 |
Why?
| Demography | 2 | 2020 | 83 | 0.360 |
Why?
| Knee Joint | 1 | 2015 | 775 | 0.360 |
Why?
| Odds Ratio | 3 | 2021 | 327 | 0.360 |
Why?
| Bone Cements | 2 | 2007 | 91 | 0.350 |
Why?
| Range of Motion, Articular | 3 | 2011 | 703 | 0.340 |
Why?
| Cerebral Palsy | 1 | 2008 | 10 | 0.340 |
Why?
| Arthroscopy | 1 | 2015 | 781 | 0.330 |
Why?
| Prognosis | 4 | 2016 | 1028 | 0.330 |
Why?
| Bone Density | 2 | 2005 | 141 | 0.320 |
Why?
| Antibiotics, Antineoplastic | 1 | 2006 | 26 | 0.310 |
Why?
| Doxorubicin | 1 | 2006 | 83 | 0.300 |
Why?
| Osteogenesis | 1 | 2006 | 94 | 0.290 |
Why?
| Pedicle Screws | 2 | 2017 | 13 | 0.290 |
Why?
| Osteomyelitis | 1 | 2006 | 23 | 0.290 |
Why?
| Epidural Space | 1 | 2006 | 22 | 0.290 |
Why?
| Surgical Wound Dehiscence | 1 | 2006 | 12 | 0.290 |
Why?
| Abscess | 1 | 2006 | 23 | 0.290 |
Why?
| Electrosurgery | 1 | 2005 | 5 | 0.280 |
Why?
| Diskectomy, Percutaneous | 1 | 2005 | 6 | 0.280 |
Why?
| Neurofibromatosis 1 | 1 | 2005 | 4 | 0.280 |
Why?
| Combined Modality Therapy | 2 | 2017 | 456 | 0.280 |
Why?
| Cryosurgery | 1 | 2005 | 30 | 0.280 |
Why?
| Biomedical Research | 2 | 2016 | 89 | 0.270 |
Why?
| Prostheses and Implants | 1 | 2006 | 166 | 0.270 |
Why?
| Catheter Ablation | 1 | 2005 | 76 | 0.260 |
Why?
| Spinal Osteophytosis | 1 | 2004 | 14 | 0.260 |
Why?
| Medicare | 2 | 2016 | 113 | 0.250 |
Why?
| Risk Assessment | 5 | 2017 | 806 | 0.250 |
Why?
| Nervous System Diseases | 2 | 2018 | 145 | 0.250 |
Why?
| Implants, Experimental | 1 | 2004 | 29 | 0.250 |
Why?
| Observer Variation | 2 | 2019 | 146 | 0.240 |
Why?
| Blood Transfusion | 3 | 2017 | 68 | 0.230 |
Why?
| Disease Models, Animal | 2 | 2007 | 832 | 0.230 |
Why?
| North America | 2 | 2017 | 44 | 0.230 |
Why?
| Prosthesis Design | 2 | 2020 | 511 | 0.220 |
Why?
| Access to Information | 1 | 2022 | 6 | 0.220 |
Why?
| Aftercare | 1 | 2022 | 24 | 0.220 |
Why?
| Deglutition | 2 | 2019 | 10 | 0.220 |
Why?
| Leg | 1 | 2022 | 51 | 0.220 |
Why?
| Predictive Value of Tests | 2 | 2021 | 637 | 0.210 |
Why?
| Cost-Benefit Analysis | 1 | 2022 | 153 | 0.210 |
Why?
| Rabbits | 4 | 2011 | 326 | 0.200 |
Why?
| Symptom Assessment | 1 | 2020 | 24 | 0.190 |
Why?
| Sample Size | 1 | 2020 | 26 | 0.190 |
Why?
| Dysphonia | 1 | 2019 | 6 | 0.190 |
Why?
| Spinal Fractures | 3 | 2005 | 63 | 0.190 |
Why?
| Fees and Charges | 1 | 2019 | 8 | 0.190 |
Why?
| Equipment Design | 1 | 2020 | 198 | 0.190 |
Why?
| Risk | 1 | 2020 | 228 | 0.190 |
Why?
| Disabled Persons | 1 | 2021 | 119 | 0.180 |
Why?
| Research Personnel | 1 | 2019 | 22 | 0.180 |
Why?
| ROC Curve | 1 | 2019 | 153 | 0.180 |
Why?
| Biomechanical Phenomena | 4 | 2006 | 719 | 0.180 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2021 | 375 | 0.180 |
Why?
| Pain | 1 | 2022 | 336 | 0.180 |
Why?
| Ambulatory Care Facilities | 1 | 2019 | 42 | 0.180 |
Why?
| Sensitivity and Specificity | 3 | 2005 | 580 | 0.170 |
Why?
| Aging | 1 | 2009 | 1614 | 0.170 |
Why?
| Enterocolitis, Pseudomembranous | 1 | 2018 | 16 | 0.170 |
Why?
| Colitis | 1 | 2018 | 34 | 0.170 |
Why?
| Hematocrit | 1 | 2017 | 15 | 0.170 |
Why?
| Urea | 1 | 2017 | 9 | 0.170 |
Why?
| Publications | 1 | 2017 | 12 | 0.160 |
Why?
| Creatinine | 1 | 2017 | 59 | 0.160 |
Why?
| Decision Support Techniques | 1 | 2017 | 55 | 0.160 |
Why?
| Child | 4 | 2021 | 1572 | 0.160 |
Why?
| Animals | 7 | 2011 | 5312 | 0.160 |
Why?
| Survival Analysis | 1 | 2018 | 379 | 0.160 |
Why?
| Exercise | 1 | 2021 | 454 | 0.150 |
Why?
| Proportional Hazards Models | 1 | 2018 | 390 | 0.150 |
Why?
| Osteoporosis | 2 | 2009 | 74 | 0.150 |
Why?
| Radiography, Thoracic | 1 | 2016 | 39 | 0.150 |
Why?
| Radiation Dosage | 1 | 2016 | 35 | 0.150 |
Why?
| Datasets as Topic | 1 | 2016 | 5 | 0.150 |
Why?
| Athletes | 1 | 2017 | 77 | 0.150 |
Why?
| Child, Preschool | 2 | 2013 | 786 | 0.150 |
Why?
| Physician-Patient Relations | 1 | 2016 | 47 | 0.140 |
Why?
| Infant | 2 | 2020 | 642 | 0.140 |
Why?
| Operating Rooms | 1 | 2015 | 18 | 0.140 |
Why?
| Diffusion Chambers, Culture | 1 | 2015 | 1 | 0.140 |
Why?
| Ligamentum Flavum | 1 | 2015 | 6 | 0.140 |
Why?
| Insurance, Health, Reimbursement | 1 | 2015 | 16 | 0.140 |
Why?
| Hospital Charges | 1 | 2015 | 23 | 0.140 |
Why?
| Spinal Nerve Roots | 1 | 2015 | 29 | 0.140 |
Why?
| Health Expenditures | 1 | 2015 | 20 | 0.140 |
Why?
| Double-Blind Method | 2 | 2007 | 559 | 0.140 |
Why?
| Longevity | 1 | 2015 | 35 | 0.140 |
Why?
| Psychiatric Status Rating Scales | 1 | 2016 | 386 | 0.140 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 42 | 0.140 |
Why?
| Hematologic Tests | 1 | 2014 | 6 | 0.130 |
Why?
| Return to Work | 1 | 2015 | 53 | 0.130 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 32 | 0.130 |
Why?
| Drug Utilization Review | 1 | 2014 | 7 | 0.130 |
Why?
| Perioperative Period | 1 | 2014 | 13 | 0.130 |
Why?
| Drug Costs | 1 | 2014 | 18 | 0.130 |
Why?
| Seasons | 1 | 2014 | 36 | 0.130 |
Why?
| Time | 1 | 2013 | 22 | 0.120 |
Why?
| Clinical Competence | 1 | 2016 | 274 | 0.120 |
Why?
| Elective Surgical Procedures | 1 | 2014 | 55 | 0.120 |
Why?
| Pseudarthrosis | 1 | 2013 | 13 | 0.120 |
Why?
| Rotation | 2 | 2004 | 158 | 0.120 |
Why?
| Neoplasms | 1 | 2016 | 280 | 0.120 |
Why?
| Cross-Sectional Studies | 1 | 2016 | 986 | 0.120 |
Why?
| Postoperative Hemorrhage | 1 | 2013 | 31 | 0.120 |
Why?
| Insurance Claim Review | 1 | 2012 | 6 | 0.120 |
Why?
| Perception | 1 | 2013 | 92 | 0.120 |
Why?
| Cattle | 2 | 2011 | 260 | 0.110 |
Why?
| Population Surveillance | 1 | 2013 | 127 | 0.110 |
Why?
| Cadaver | 2 | 2004 | 356 | 0.110 |
Why?
| Activities of Daily Living | 1 | 2015 | 495 | 0.110 |
Why?
| Substance-Related Disorders | 1 | 2013 | 115 | 0.110 |
Why?
| Spinal Neoplasms | 1 | 2012 | 36 | 0.110 |
Why?
| Myocardial Infarction | 1 | 2013 | 187 | 0.110 |
Why?
| United States Food and Drug Administration | 1 | 2012 | 75 | 0.110 |
Why?
| DNA | 2 | 2009 | 139 | 0.100 |
Why?
| Retreatment | 1 | 2011 | 18 | 0.100 |
Why?
| Infant, Newborn | 1 | 2013 | 754 | 0.100 |
Why?
| Spinal Nerves | 1 | 2010 | 6 | 0.100 |
Why?
| Heart Failure | 1 | 2013 | 232 | 0.100 |
Why?
| Decorin | 1 | 2009 | 19 | 0.090 |
Why?
| Biglycan | 1 | 2009 | 17 | 0.090 |
Why?
| Keratan Sulfate | 1 | 2009 | 27 | 0.090 |
Why?
| Chondroitin Sulfate Proteoglycans | 1 | 2009 | 47 | 0.090 |
Why?
| Dogs | 2 | 2007 | 283 | 0.090 |
Why?
| Infusions, Parenteral | 1 | 2007 | 14 | 0.080 |
Why?
| Extracellular Matrix Proteins | 1 | 2009 | 176 | 0.080 |
Why?
| Drug Administration Schedule | 1 | 2007 | 257 | 0.080 |
Why?
| Edema | 1 | 2006 | 40 | 0.070 |
Why?
| Chemotherapy, Adjuvant | 1 | 2006 | 109 | 0.070 |
Why?
| Hydromorphone | 1 | 2005 | 3 | 0.070 |
Why?
| Blood Sedimentation | 1 | 2006 | 65 | 0.070 |
Why?
| Creatine Kinase | 1 | 2006 | 36 | 0.070 |
Why?
| Infusion Pumps | 1 | 2005 | 16 | 0.070 |
Why?
| Therapeutic Irrigation | 1 | 2006 | 69 | 0.070 |
Why?
| Cricetinae | 1 | 2005 | 52 | 0.070 |
Why?
| Lasers | 1 | 2005 | 15 | 0.070 |
Why?
| Headache | 1 | 2006 | 52 | 0.070 |
Why?
| Debridement | 1 | 2006 | 99 | 0.070 |
Why?
| Staphylococcus aureus | 1 | 2006 | 87 | 0.070 |
Why?
| Surgical Flaps | 1 | 2006 | 54 | 0.070 |
Why?
| Chondroitin ABC Lyase | 1 | 2005 | 6 | 0.070 |
Why?
| Biopsy, Needle | 1 | 2005 | 117 | 0.070 |
Why?
| Stress, Mechanical | 1 | 2005 | 198 | 0.070 |
Why?
| Spinal Cord | 1 | 2006 | 99 | 0.070 |
Why?
| Mice, Knockout | 1 | 2005 | 399 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2005 | 494 | 0.060 |
Why?
| Case-Control Studies | 1 | 2006 | 687 | 0.060 |
Why?
| Endoscopy | 1 | 2005 | 181 | 0.060 |
Why?
| Staphylococcal Infections | 1 | 2006 | 176 | 0.060 |
Why?
| Clinical Laboratory Techniques | 1 | 2004 | 38 | 0.060 |
Why?
| Fracture Fixation, Internal | 1 | 2004 | 71 | 0.060 |
Why?
| Rats | 1 | 2005 | 966 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2006 | 412 | 0.060 |
Why?
| Muscle, Skeletal | 1 | 2006 | 385 | 0.060 |
Why?
| Longitudinal Studies | 1 | 2006 | 1452 | 0.050 |
Why?
| Transplantation, Homologous | 1 | 2002 | 292 | 0.050 |
Why?
| Mice | 1 | 2005 | 1894 | 0.050 |
Why?
| Data Mining | 1 | 2017 | 5 | 0.040 |
Why?
| Qualitative Research | 1 | 2018 | 127 | 0.040 |
Why?
| Fluoroscopy | 1 | 2017 | 54 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2017 | 1240 | 0.040 |
Why?
| Sepsis | 1 | 2018 | 157 | 0.040 |
Why?
| Bone Morphogenetic Protein 7 | 2 | 2005 | 65 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 276 | 0.030 |
Why?
| Evidence-Based Medicine | 1 | 2016 | 239 | 0.030 |
Why?
| Allografts | 1 | 2015 | 171 | 0.030 |
Why?
| Compressive Strength | 1 | 2007 | 37 | 0.020 |
Why?
| Elasticity | 1 | 2007 | 53 | 0.020 |
Why?
| Neck | 1 | 2006 | 25 | 0.020 |
Why?
| Glucuronic Acid | 1 | 2005 | 10 | 0.020 |
Why?
| Hexuronic Acids | 1 | 2005 | 12 | 0.020 |
Why?
| Intervertebral Disc Chemolysis | 1 | 2005 | 5 | 0.020 |
Why?
| Alginates | 1 | 2005 | 12 | 0.020 |
Why?
| Glycosaminoglycans | 1 | 2005 | 69 | 0.020 |
Why?
| Injections | 1 | 2005 | 59 | 0.020 |
Why?
| Water | 1 | 2005 | 37 | 0.020 |
Why?
| In Vitro Techniques | 1 | 2005 | 248 | 0.020 |
Why?
| Bone Wires | 1 | 2004 | 12 | 0.020 |
Why?
|
|
Singh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|